Therapy News and Research

RSS

Study reports new potential NOX inhibitor therapy for liver fibrosis

A study published in the online journal Hepatology reports a potential new NADPH oxidase (NOX) inhibitor therapy for liver fibrosis, a scarring process associated with chronic liver disease that can lead to loss of liver function.

8 Aug 2012

Healthcare professionals receive SingHealth Duke-NUS Scientific Congress abstract awards

Results of the highly anticipated Best Oral Presentation and Best Poster Awards were announced at SingHealth Duke-NUS Scientific Congress 2012, held on 3 and 4 August 2012 at the Raffles City Convention Centre.

8 Aug 2012

New class of drugs reduces adverse effects of cellular damage from cancer chemotherapy

Chemotherapy kills tumor cells, but it also wreaks havoc on the rest of the body. A team of researchers led by Igor Roninson of the South Carolina College of Pharmacy just reported the discovery of a new class of drugs that reduces the adverse effects of cellular damage from chemotherapy.

8 Aug 2012

UMass Medical, Serum Institute of India partner on anti-rabies monoclonal antibody pivotal trial

A pivotal clinical trial for an anti-rabies human monoclonal antibody (RMAb) being developed through a collaborative partnership between MassBiologics of the University of Massachusetts Medical School and the Serum Institute of India, Ltd., is starting to enroll patients.

8 Aug 2012

Older men with higher levels of free testosterone more likely to develop prostate cancer

New research finds older men with higher levels of free testosterone have an increased risk of prostate cancer. Australian researchers spent a decade exploring the testosterone-prostate cancer connection by comparing natural testosterone levels of men in their 70s and 80s, those with prostate cancer and without.

8 Aug 2012

Early maladaptive schemas play role in bipolar disorder functionality

Results from a Danish study suggest that seven early maladaptive schemas play a significant role in functional impairment among patients with bipolar disorder.

7 Aug 2012

Cryotherapy effective for treating frozen shoulder

In patients with adhesive capsulitis of the shoulder, the addition of whole-body cryotherapy to physical therapy and joint mobilization appears to be more effective than the latter two alone, research shows.

7 Aug 2012

Back pain sufferers show quick response to chiropractic therapy

Patients with low back pain undergoing chiropractic treatment who respond to treatment are likely to improve very quickly, study findings show.

7 Aug 2012

Pets may trigger ‘prosocial’ behavior in autistic children

Autistic children show improvements in certain aspects of prosocial behavior after the introduction of pets into the family home, researchers report.

7 Aug 2012

Creating new non-influenza vaccines: an interview with Julie Phillips, CEO of BioDiem

BioDiem recently signed a collaborative agreement with The Royal Melbourne Institute of Technology (RMIT) for the development of non-influenza vaccines using BioDiem’s proprietary live attenuated influenza virus (LAIV) technology.

7 Aug 2012

Advances in HIV/AIDS therapy and the International AIDS Conference: an interview with Professor Sharon Lewin

The anti-HIV drugs, also known as anti-retroviral therapy, came about in the mid ‘90’s. These involved using at least 3 different drugs together.

7 Aug 2012

NYUCN professor to investigate efficacy of Acu/Moxa in managing irritable bowel syndrome

New York University College of Nursing's (NYUCN) Joyce K. Anastasi, PhD, DrNP, FAAN, LAc., the Independence Foundation Endowed Professor and Founding Director of the Division of Special Studies in Symptom Management at NYUCN has been awarded a $2.5 million four-year National Institutes of Health (NIH) grant for the study of "Symptom management for irritable bowel syndrome (IBS) constipation".

7 Aug 2012

Scientists discover biological marker that may help identify patients’ response to antidepressants

Scientists have discovered a biological marker that may help to identify which depressed patients will respond to an experimental, rapid-acting antidepressant. The brain signal, detectable by noninvasive imaging, also holds clues to the agent's underlying mechanism, which are vital for drug development, say National Institutes of Health researchers.

7 Aug 2012

Blood levels of IL-6 protein may also serve as red flag for relapse in schizophrenia patients

Blood levels of a protein that helps regulate inflammation may also serve as a red flag for relapse in some schizophrenia patients, researchers said.

7 Aug 2012

Novartis’ pasireotide offers symptom relief for patients with advanced neuroendocrine tumors

A researcher at Moffitt Cancer Center and his international team of colleagues have reported study results on a novel multireceptor-targeted somatostatin analogue called pasireotide (SOM230) manufactured by Novartis Pharma AG.

7 Aug 2012

Adalimumab effective in maintaining remission in pediatric patients with Crohn's disease

Adalimumab (an anti-tumor necrosis factor [TNF] antibody) is effective in maintaining remission in certain pediatric patients with Crohn's disease, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association.

7 Aug 2012

Therapy News and Research

Study reports new potential NOX inhibitor therapy for liver fibrosis

Healthcare professionals receive SingHealth Duke-NUS Scientific Congress abstract awards

New class of drugs reduces adverse effects of cellular damage from cancer chemotherapy

UMass Medical, Serum Institute of India partner on anti-rabies monoclonal antibody pivotal trial

Older men with higher levels of free testosterone more likely to develop prostate cancer

Early maladaptive schemas play role in bipolar disorder functionality

Cryotherapy effective for treating frozen shoulder

Back pain sufferers show quick response to chiropractic therapy

Pets may trigger ‘prosocial’ behavior in autistic children

Creating new non-influenza vaccines: an interview with Julie Phillips, CEO of BioDiem

Advances in HIV/AIDS therapy and the International AIDS Conference: an interview with Professor Sharon Lewin

NYUCN professor to investigate efficacy of Acu/Moxa in managing irritable bowel syndrome

Scientists discover biological marker that may help identify patients’ response to antidepressants

Blood levels of IL-6 protein may also serve as red flag for relapse in schizophrenia patients

Novartis’ pasireotide offers symptom relief for patients with advanced neuroendocrine tumors

Adalimumab effective in maintaining remission in pediatric patients with Crohn's disease

Exercise hope for drug-resistant hypertension

Vorinostat drives HIV from hiding

Pendrin a possible new target for diuretic therapy

Boric acid treatment equals best practice for otitis media

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News